SIRPA and brain neoplasm: By antagonizing CD47 (which binds to activating signal regulatory protein-alpha (SIRPalpha) on myeloid cells) with a humanized mAb, pre-clinical investigations have demonstrated that macrophages can be unlocked to phagocytize tumor cells in several pediatric brain tumor models [69].